O que significa “Limpar”?
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Discover the importance of DNA testing for Canine Leukocyte Adhesion Deficiency (CLAD) in dogs. CLAD is a serious genetic disorder affecting the immune system, making dogs more susceptible to infections. Early detection through a simple DNA test can help pet owners make informed breeding decisions and ensure healthier puppies. Understanding CLAD allows for better management of affected dogs, improving their quality of life. This test is crucial for breeds prone to this condition, such as Irish Setters. Protect your furry friend with proactive measures by opting for a CLAD DNA test today. Invest in your dog’s health and well-being—knowledge is power!
Canine Leukocyte Adhesion Deficiency (CLAD) is a genetic disorder that affects the immune system of dogs, particularly prevalent in certain breeds like the Irish Setter. This condition impairs the ability of white blood cells to adhere to blood vessel walls, leading to increased susceptibility to infections. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions to reduce the incidence of CLAD in future generations. Early detection through testing is crucial for managing the health of affected dogs. Responsible breeding practices can help eliminate this debilitating condition from the gene pool.
Este teste de DNA está incluído a partir do nosso pacote Basic - e também faz parte dos packs Basic, Standard, Advanced, Complete.
Ver pacotes de teste de DNA →Canine Leukocyte Adhesion Deficiency (CLAD) is a genetic disorder primarily affecting the immune system of dogs. It is caused by a mutation in a specific gene that is responsible for the development and function of leukocytes, or white blood cells. This condition leads to an inability of leukocytes to adhere to blood vessel walls, which is crucial for their migration to sites of infection or inflammation.
Dogs affected by CLAD typically exhibit a range of clinical signs due to their compromised immune response. Common symptoms include recurrent infections, poor wound healing, and chronic inflammation. Affected dogs may also show signs of systemic illness, such as fever, lethargy, and weight loss. The severity of these symptoms can vary widely among individuals, depending on the extent of their immune dysfunction.
The diagnosis of CLAD is primarily achieved through genetic testing. A DNA test specifically designed to identify the mutation associated with CLAD can confirm the diagnosis. This test is crucial for breeders and dog owners to understand the genetic status of their dogs and to make informed breeding decisions. Early detection can also help in managing the health of affected dogs more effectively.
Currently, there is no cure for CLAD; however, management strategies can be employed to improve the quality of life for affected dogs. Treatment often involves prompt and aggressive management of infections with antibiotics and supportive care. Additionally, owners may need to take extra precautions to minimize exposure to pathogens, such as avoiding dog parks or other areas where dogs congregate.
Genetic testing for CLAD is vital for responsible breeding practices. By identifying carriers and affected individuals, breeders can make informed decisions to avoid producing affected puppies. This not only helps in reducing the prevalence of the condition in the population but also promotes overall canine health and welfare.
Canine Leukocyte Adhesion Deficiency is a serious genetic condition that poses significant health challenges for affected dogs. Understanding this disorder, recognizing its symptoms, and utilizing genetic testing are essential steps in managing the condition and ensuring the health of future generations of dogs. By prioritizing genetic health, dog owners and breeders can contribute to a healthier canine population.
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Não. O animal é geralmente saudável, mas pode transmitir a mutação ao seu descendência.
Ele carrega duas cópias mutadas. Os sinais clínicos são esperados dependendo a doença. Não deveria ser criado.
Algumas doenças estão ligadas ao sexo, pelo que a sua expressão varia dependendo do sexo do animal.
This DNA test detects the mutation associated with Canine Leukocyte Adhesion Deficiency (CLAD) in order to identify clear, carrier, or at-risk animals.
Os testes de DNA ajudam os criadores a planejar acasalamentos mais seguros e a reduzir o risco de transmissão da mutação aos descendentes.
O modo de herança relatado para este teste é Autossômico Recessivo.
This test analyses the mutation ITGB2 c.107G>C.
Não necessariamente. A interpretação depende do padrão de herança e do genótipo resultante.
Kijas J M, Bauer T R Jr, Gäfvert S, Marklund S, TrowaldWigh G, Johannisson A, Hedhammar A, Binns M, Juneja R K, Hickstein D D, Andersson L. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics. 1999 Oct 1;61(1):101-7. doi: 10.1006/geno.1999.5948.
Sua privacidade, sua escolha
Usamos cookies essenciais para operar o site. Cookies opcionais (como provedores de conteúdo incorporados) estão desabilitados por padrão e só são habilitados se você concordar. Você pode alterar sua escolha a qualquer momento através do botão “Cookies”.
Necessário para recursos básicos e segurança. Sempre habilitado.
Melhora recursos como salvamento de preferências ou incorporações não publicitárias.
Ajuda-nos a entender o uso do site. Desativado por padrão.
Publicidade/rastreamento em sites (algumas incorporações de vídeos/mapas). Desativado por padrão.